Global Director, Oncology Evidence Generation

Bristol Myers Squibb; Madison (NJ); Hybrid; USD 207,000 - 251,000; Full time

Job summary

Bristol Myers Squibb is seeking a Director of Medical Evidence Generation in Medical Affairs to lead strategic development and execution of an evidence plan for GI/GU oncology assets. The role involves collaborations across Medical Strategy, RWE, Clinical Operations, and external investigators.

You will guide protocol development, governance, and study design for Phase II/IV trials and real-world evidence, ensuring compliant, high-quality execution. Based in NJ with hybrid work options.

Qualifications

• Advanced scientific degree required with extensive development experience.
• Experience in pharmaceutical clinical development, Medical Affairs, or related commercial areas.
• Deep oncology knowledge focused on GI/GU cancers.
• Ability to analyze data generation opportunities and review study design elements.
• Strong execution and leadership across cross-functional teams.

Responsibilities

• Define and drive the integrated evidence generation strategy across trials, RWE, registries, and observational studies.
• Assess research concepts for alignment with company priorities and objectives.
• Lead study design and governance from concept to completion; engage external partners.
• Ensure GCP/ICH compliance and high-quality study execution.
• Collaborate with Clinical Operations and CROs to deliver studies on time and budget.
• Contribute to scientific dissemination through publications and forums.

Skills

Oncology expertise

Strategic thinking

Cross-functional leadership

Scientific communication

Travel willingness

Education

MD/PhD/PharmD/MS

Job description

Bristol Myers Squibb is seeking a Director of Medical Evidence Generation in Medical Affairs to lead strategic development and execution of an evidence plan for GI/GU oncology assets. The role involves collaborations across Medical Strategy, RWE, Clinical Operations, and external investigators.

You will guide protocol development, governance, and study design for Phase II/IV trials and real-world evidence, ensuring compliant, high-quality execution. Based in NJ with hybrid work options.